BioMedWire Stocks

Robots Could Ease Order Fulfilment for eCommerce Companies

Small- to medium-sized e-commerce companies sometimes face challenges with fulfilling orders, especially when one considers the costs incurred when managing warehouses and fulfilment centers. To make it easier, most of these companies outsource the tasks.

It is expected, however, that robots may soon take up these tasks as warehouse automation is adopted more by smaller companies. A recent report by Gartner forecasts that the warehouse automation industry will generate more that $21 billion in revenue globally this year. This is expected to hit $71 billion by 2032.

Most of the revenue generated and growth observed in the industry can be attributed to logistics business and large retailers. Current focus on big companies has placed warehouse automation out of reach for small and midsized businesses, primarily because warehouse systems are too complex and big for small businesses. Additionally, automated warehouse solutions are costly, so it doesn’t make sense for small businesses to invest in automation until they have volume and scale.

To help small businesses, warehouse automation companies such as Prime Robotics, Dexterity Inc., Pio and BionicHive have began aiming their services and products at e-commerce small businesses to reach new sellers. For instance, the P100 cube by Pio has been designed to pick products and store them efficiently. This machine, which is basically a high-speed vending machine, is retailing for $101,999, with a monthly fee of $2,997.

Pio’s cube package comes with a pair of picking robots. Users who wish to add another robot can pay a monthly fee of $3,996. Each of these robots can pick roughly 120 items in one hour and can work alongside other fulfilment operations, which eliminates the need for a separate system to manage the warehouse.

Pio has, thus far, conducted five cube-and-robot installations at AI Stone, Barnes 4WD, Souko, Sunday Swagger, and the Privada Cigar Club. How these brands perform in the near-to-long term could forecast e-commerce fulfilment in general. Meanwhile, BionicHive has manufactured a 100-pound, two-foot-wide robot that can run along warehouse shelves and aisles, picking orders without any help. The robot, dubbed Squid, is suitable for big and medium-sized businesses.

It is expected that the growing trend toward e-commerce that small- and medium-sized companies in the warehouse automation industry are exhibiting will afford growing brands more fulfilment options. Whether small-scale robotics and warehouse automation systems save money for e-commerce companies and provide them with competitive advantage over other companies remains to be seen though.

Robotics isn’t the only aspect that is growing within the ecommerce field. Companies such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) are bringing next-generation approaches to specialized segments like healthcare ecommerce to ensure that sellers and consumers receive exactly what they want with minimal hassle.

NOTE TO INVESTORS: The latest news and updates relating to NextPlat Corp. (NASDAQ: NXPL, NXPLW) are available in the company’s newsroom at https://ibn.fm/NXPL

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Liquid Biopsy Forecasts Response to Immunotherapy in Lung Cancer Patients

While immunotherapy is revolutionizing cancer therapy, response rates to these novel treatments are low and some patients…

12 hours ago

Surgeon, Payer, Patient Win: The Economic and Workflow Advantages Positioning GelrinC as a New Standard of Care for Knee Cartilage Repair

Regentis recently received European regulatory approval for a next-generation GelrinC manufacturing process that increases production…

1 day ago

VERAXA Biotech AG (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies 

The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program into the next stage…

2 days ago

As Cases of Measles Rise, US Officials Double Down on Contact Tracing and Vaccination

As July came to an end, the United States reached an undesirable milestone: exceeding the…

3 days ago

Climate Change is Accelerating the Spread of Infectious Diseases, Experts Warn

Scientists and public health experts are warning that climate change is accelerating the rate at which infectious…

7 days ago

Novel Vitamin B12 Treatment Offers Hope in Brain Cancer Treatment

Glioblastoma multiforme (GBM) is the deadliest type of brain cancer and patients usually die within 15 months…

1 week ago